Robert Rintoul, BSc, MB ChB, PhD, FRCP, discusses the importance of minimal residual disease assessment in patients with non–small cell lung cancer.
Robert Rintoul, BSc, MB ChB, MRCP, PhD, FRCP
Advertisement
Articles by Robert Rintoul, BSc, MB ChB, MRCP, PhD, FRCP
Advertisement
Latest Updated Articles
Dr. Rintoul on the Importance of MRD Assessment in NSCLCJune 22nd 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL
4
Sonrotoclax and Next-Generation BCL-2 Inhibitors for Treating CLL
5